Also known as: Nonathymulin · Thymulin · Thymic factor
Human (controlled)Mixed
On this page
- What is thymalin?
- How does thymalin work?
- What does the research show?
- What the community reports
- Is thymalin safe? Side effects
- FDA & legal status (2026)
- How is thymalin used, and can it be mixed?
- Thymalin vs thymosin — and the wider landscape
- Frequently asked questions
- Who is thymalin for — and who should be cautious?
- Evidence by outcome
- FDA & legal status
- Chemical identifiers
- References
- Related compounds
- More on Thymalin
Thymalin is a thymus-derived peptide preparation, developed in Soviet-era Russia, that has been studied in people mainly for restoring immune function and slowing some markers of aging. Thymalin is not FDA-approved and is sold in the US only as a research chemical. The human evidence is real but comes largely from one research group.
Say you’re in your fifties, you seem to catch every bug going around the office, and somewhere in a longevity forum you read that an old Russian “thymus peptide” might tune your immune system back up. That is almost always the thread that leads people to thymalin — and it’s a more interesting case than most research peptides, because thymalin has actually been given to humans for decades. The question is how good that evidence really is.
What is thymalin?
Thymalin is a polypeptide preparation extracted from the thymus — the small organ behind your breastbone that acts as a training academy for T-cells, the immune system’s front-line soldiers. It was developed by Russian researchers (the St. Petersburg Institute of Bioregulation and Gerontology group associated with Vladimir Khavinson and Vyacheslav Morozov) and has been used as a prescription immunomodulator in Russia. Importantly, thymalin is a mixture of small thymic peptides purified from animal tissue, not a single synthetic molecule.
That matters for one confusing detail. Chemical databases such as PubChem index “thymalin” under a specific nonapeptide — a 9-amino-acid chain (pGlu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn, formula C33H54N12O15, molecular weight ≈ 858.9) that also goes by the names thymulin and nonathymulin. So if you look thymalin up, you’ll see it treated as that single nonapeptide, while the clinical product is better described as a thymic peptide complex. It’s a naming overlap worth knowing about before you read too much into any one structure.
How does thymalin work?
Thymalin’s proposed mechanism is about the thymus itself. Think of the thymus as a boot camp where immature immune cells are trained to tell friend from foe; the problem is that this boot camp physically shrinks and quiets down as you age, which is one reason immune function tends to slip in older people. The idea behind thymalin, drawn largely from older Russian research, is that supplying thymic peptides helps keep that training signal going — nudging T-cell maturation and rebalancing an immune system that has drifted out of tune. That is a plausible story rooted in real thymic biology, but the precise molecular mechanism in a human body is not established, and “restores the thymus” is a claim that has to be read as a working hypothesis rather than a proven pathway.
What does the research show?
Thymalin is one of the few research-market peptides with genuine human data — a PubMed search returns roughly 293 records, about 195 of them tagged human, including a small number of randomized-trial-tagged reports and around nine reviews. Its best-documented use is restoring cell-mediated immunity in people whose immune function is weakened, and its longevity claim is that long-term courses in older adults improved physiological markers and, on follow-up, were reported alongside lower mortality.
Here’s the honest framing, and it’s the whole point of this page. Almost all of that human work traces back to a single research group in St. Petersburg, and much of it predates modern trial-reporting standards (registration, blinding details, published raw data). That “one group, many papers” pattern is the same replication weakness we flag for BPC-157, and it means thymalin sits at controlled human evidence — better than the rat-only data behind most research peptides, but not the independently-replicated, high-rigor RCT base you’d want before treating the longevity claim as settled. We grade thymalin’s immune-restoration use as helped under controlled conditions and its geroprotection claim as mixed — a real human signal carrying a large asterisk, not proof.
What the community reports
Outside the clinic, thymalin has a following in longevity and biohacking circles, often mentioned in the same breath as epitalon as part of a “Khavinson peptides” anti-aging routine. The commonly reported pattern is short injected courses a couple of times a year, aimed at “immune resets” and general aging. These accounts are anecdotal — uncontrolled personal reports, subject to placebo and survivorship bias (people who notice nothing tend to stop posting), and they can’t tell you how often thymalin does nothing. They’re useful for understanding why people are curious, not for judging whether it works.
Is thymalin safe? Side effects
Thymalin’s honest safety picture is unusual: it has a long real-world use history — decades as a registered immunomodulator in Russia, where it was generally described as well tolerated — but that is not the same as modern long-term safety data, which is thin by Western standards. The most substance-specific concern is that thymalin is extracted from animal thymus tissue rather than synthesized, so like any tissue-derived biologic it carries a theoretical risk of allergic or immune reactions and of contamination if purification is poor. Because it acts on the immune system, people who are pregnant, immunosuppressed, managing an autoimmune condition, or on immune-modifying drugs have obvious reasons for caution. And the most concrete real-world risk is the product itself: US-sold thymalin is an unregulated research chemical, so its purity, dose accuracy and sterility hinge on which supplier you happen to buy from.
FDA & legal status (2026)
Thymalin is not FDA-approved and is not a legal dietary supplement in the United States, where it is sold strictly as a research chemical (“for research use only”). No approved thymalin product appears in FDA’s drug records as of 2026. The important nuance is geographic: thymalin has long been a registered prescription immunomodulator in Russia, so “not approved” is a statement about the US, not the world. Treat any status claim as dated and re-check it; the dated breakdown is in the FDA & legal status block above.
How is thymalin used, and can it be mixed?
In its clinical history thymalin was given as intramuscular injections in short courses, after being reconstituted from a freeze-dried powder — that route is well-established, though we’re not going to attach specific milligram protocols here because the dosing figures floating around research-chemical listings aren’t tied to a citable study we can stand behind. Treat any number you see as information, not a prescription. If you are working from a source you trust, the arithmetic of turning a powder vial into an injectable concentration is exactly what our reconstitution & dosing calculator handles. People also ask whether thymalin can share a syringe with other peptides; our mixing compatibility reference covers what is commonly combined and where the honest answer is “not enough data” — and for an animal-derived extract, sterility matters more than usual.
Thymalin vs thymosin — and the wider landscape
Thymalin often gets confused with the thymosins, because they all come from the same organ. The quick map: thymalin is a thymic peptide complex used for immune restoration and aging, while thymosin beta-4 (the parent of TB-500) is a single, well-characterized peptide studied more for tissue repair. If your interest is the anti-aging angle specifically, thymalin’s closest sibling on this site is MOTS-c, a mitochondrial peptide pitched at metabolic aging — though MOTS-c’s evidence is still mostly animal, where thymalin’s is human. Other immune-adjacent peptides worth reading alongside it are ARA-290 and KPV. All of these live under the longevity hub in our broader peptide reference.
Frequently asked questions
Does thymalin actually work?
Thymalin has human evidence — controlled clinical studies for immune restoration, and long-term trials in older adults reporting improved markers and lower mortality. That puts it ahead of most research peptides. The honest limit is that this evidence comes largely from one research group and hasn’t been independently replicated to modern standards, so we grade it as controlled human evidence, not confirmed proof.
Is thymalin legal?
In the United States thymalin is legal to buy and sell as a research chemical, but it is not an FDA-approved drug or a legal dietary supplement and cannot be sold for human consumption. Abroad the picture differs — thymalin is a registered prescription medicine in Russia. This is why every US vendor labels it “for research use only.”
Is thymalin banned in sport?
Thymalin is not specifically named on the WADA Prohibited List, and its status is ambiguous: WADA’s S0 catch-all covers substances with no regulatory approval anywhere, and thymalin is an approved medicine in some countries, which muddies that category. Immune modulators aren’t a classic doping target either. Any athlete under anti-doping rules should confirm with their own testing authority rather than assume.
How is thymalin taken?
In its clinical use thymalin was reconstituted from a powder and injected intramuscularly in short courses. The community mirrors that route with periodic injected cycles. We don’t publish a personal dosing protocol, because the specific numbers circulating aren’t tied to a study we can cite.
Is thymalin the same as thymulin?
Not exactly, and this trips people up. Chemical databases index “thymalin” under the thymulin/nonathymulin nonapeptide, so the two names get merged online. But the clinical thymalin preparation is a complex of thymic peptides purified from tissue, while thymulin is one defined nonapeptide. Read any single structure for thymalin with that overlap in mind.
Who is thymalin for — and who should be cautious?
Thymalin draws in people focused on immune resilience and healthy aging — often someone older who feels their immune system has slipped, or a longevity enthusiast building a peptide routine. The honest framing: thymalin is one of the rare research-market peptides with real human data, which sets it apart, and its immune-restoration use is the most solid part of that record. But the evidence leans heavily on a single research group, the longevity claim is not independently confirmed, modern long-term safety data is thin, and the US product is an unregulated animal-tissue extract. Anyone pregnant, immunosuppressed, managing an autoimmune condition, on immune-modifying medication, or unwilling to accept those unknowns has good reason to wait for stronger, independent evidence.
Evidence by outcome
Each outcome Thymalin has been studied for, with the honest evidence grade and what the studies actually found. A tier never stands alone — the verdict rides with it.
| Outcome | Evidence | What was found |
|---|---|---|
| Immune restoration (cell-mediated immunity) | Human (controlled)Helped | Thymalin's oldest and best-documented use is restoring cell-mediated immunity, and unlike most research peptides it does have human data behind it — controlled clinical studies in people with weakened immune function. The catch is that this work is concentrated in one Russian research group and much of it predates modern trial-reporting standards, so the honest grade is controlled human evidence, not a confirmed independent result. |
| Healthy aging / geroprotection | Human (controlled)Mixed | Thymalin's most eye-catching claim is that long-term courses in older adults improved physiological markers and, in follow-up, tracked with lower mortality. That evidence comes from multi-year controlled trials by the same St. Petersburg group and has not been independently replicated in the West, so thymalin's longevity claim is a real human signal with a large asterisk, not a settled finding. |
FDA & legal status
- United States: research use only (as of Jul 2026)
Thymalin is not an FDA-approved drug and is not a dietary supplement in the United States — it is sold only as a research chemical ("for research use only"). No approved thymalin product appears in FDA's drug records as of 2026. Note the contrast with abroad: thymalin has long been registered and used as a prescription immunomodulator in Russia, so "not approved" is a US-specific statement, not a global one. Re-verify before relying on it.
openFDA Drugs@FDA lists no approved product for Thymalin as of 2026-07-15.
Chemical identifiers
- Molecular formula
- C33H54N12O15
- Molecular weight
- 858.9 g/mol
- IUPAC name
- (2S)-4-amino-2-[[(2S)-2-[[2-[[2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]amino]hexanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoic acid
Verified external records:
References
More on Thymalin
Everything else we've written about Thymalin — what the community reports, the explainers that cover it, and the terms it keeps running into.